Your browser doesn't support javascript.
loading
Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.
Bruzzi, M; Auclin, E; Lo Dico, R; Voron, T; Karoui, M; Espin, E; Cianchi, F; Weitz, J; Buggenhout, A; Malafosse, R; Denimal, F; Le Malicot, K; Vernerey, D; Douard, R; Emile, J F; Lepage, C; Laurent-Puig, P; Taieb, J.
Afiliação
  • Bruzzi M; Department of General and Digestive Surgery, Georges Pompidou European Hospital, AP-HP, Paris, France. matthieu.bruzzi@aphp.fr.
  • Auclin E; Department of Digestive Oncology, Georges Pompidou European Hospital, AP-HP, Paris, France.
  • Lo Dico R; Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, Besançon, France.
  • Voron T; Department of Digestive and Oncological Surgery, Lariboisière Hospital, AP-HP, Paris, France.
  • Karoui M; Department of Digestive and General Surgery, Saint Antoine Hospital, AP-HP, Sorbonne Université, Paris, France.
  • Espin E; Department of Digestive and Hepato-Pancreato-Biliary Surgery, Pitié-Salpêtrière University Hospital, AP-HP, Paris VI University Institute of Cancerology, Paris, France.
  • Cianchi F; Department of General Surgery, Hospital Valle de Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
  • Weitz J; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Buggenhout A; Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus of the Technical University Dresden, Dresden, Germany.
  • Malafosse R; Department of Surgical Gastroenterology, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.
  • Denimal F; Department of Digestive Surgery, Ambroise-Paré Hospital, AP-HP, Boulogne, France.
  • Le Malicot K; Department of Digestive Surgery, Centre Hospitalier Départemental Vendée, La Roche Sur Yon, France.
  • Vernerey D; Statistical Department, Fédération Francophone de Cancérologie Digestive, EPICAD, INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, Dijon, France.
  • Douard R; Methodological and Quality of Life in Oncology Unit, EA 3181, University Hospital of Besançon, Besançon, France.
  • Emile JF; Department of General and Digestive Surgery, Georges Pompidou European Hospital, AP-HP, Paris, France.
  • Lepage C; Pathology Department, Ambroise-Paré Hospital, AP-HP, Boulogne, France.
  • Laurent-Puig P; Hepato-Gastroenterology Department, Dijon University Hospital and EPICAD INSERM LNC-UMR 1231, University of Burgundy and Franche Comté, Dijon, France.
  • Taieb J; Department of Biology, European Georges Pompidou Hospital, AP-HP, INSERM-UMR-S1147, Paris, France.
Ann Surg Oncol ; 26(11): 3561-3567, 2019 Oct.
Article em En | MEDLINE | ID: mdl-31209667
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo / Proteínas ras / Proteínas Proto-Oncogênicas B-raf / Mutação / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo / Proteínas ras / Proteínas Proto-Oncogênicas B-raf / Mutação / Recidiva Local de Neoplasia Idioma: En Ano de publicação: 2019 Tipo de documento: Article